Dactolisib
id:
dactolisib-185-791850
title:
Dactolisib
text:
Dactolisib is an imidazoquinoline derivative acting as a PI3K inhibitor. It also inhibits mTOR. It is being investigated as a possible cancer treatment. It has been shown to be toxic to Waldenström's macroglobulinemia cells. It was the first PI3K inhibitor to enter clinical trials, in 2006. A phase IB/II clinical trial for locally advanced or metastatic HER2 negative breast cancer has completed. A phase II clinical trial for advanced pancreatic neuroendocrine tumors (pNET) had initially reported
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/Dactolisib
date created:
2010-08-25T15:35:28Z
date modified:
2024-09-07T14:49:31Z
main entity:
{"identifier":"Q4835503","url":"https://www.wikidata.org/entity/Q4835503"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/9/9f/Dactolisib.svg","width":512,"height":385}
fields total:
13
integrity:
16